hope rugo, md, considers the incidence of tnbc and what makes this disease so difficult to treat
Published 3 years ago • 67 plays • Length 2:02Download video MP4
Download video MP3
Similar videos
-
4:54
hope rugo, md, shares the design and outcomes of keynote-355 presented at sabcs 2020
-
0:53
keynote-522 demonstrates potential for immunotherapy in triple-negative breast cancer
-
14:56
gs1 03 discussant hope s rugo
-
2:02
triple-negative breast cancer: what you need to know
-
10:09
hope rugo, md: advances and challenges in the treatment of metastatic breast cancer
-
22:00
top secrets of healing triple negative breast cancer| my learnings for life | 2024-03-01
-
33:34
sharing my her2 breast cancer diagnosis story at 35 years old
-
43:41
revolutionising triple negative breast cancer treatment
-
3:31
hope rugo, md, examines data from the destiny-breast01 clinical study presented at sabcs 2020
-
5:53
treating early-stage tnbc
-
1:02:57
peri-operative therapy in urothelial carcinoma: uromigos live 2024
-
0:59
expert discusses the value of combination treatment in tnbc treatment
-
10:06
triple negative breast cancer: what you need to know
-
4:55
triple negative breast cancer: what you need to know
-
7:20
ar-targeted therapy and immunotherapy for tnbc
-
4:47
brain metastases developed from her2 postive and triple negative breast cancer
-
49:25
optimizing therapy in her2 disease with dr. hope s. rugo
-
1:14
the importance of a biomarker-directed approach in triple-negative breast cancer
-
11:50
triple negative breast cancer
-
11:53
new developments in triple-negative breast cancer therapies - medpage today
-
4:20
keynote-522: 5-year follow-up of pembrolizumab in triple-negative breast cancer
-
24:28
triple negative breast cancer